ALS' (ASX:ALQ) expected improvement in sampling flows through the second half of fiscal 2025 and further improvement in fiscal 2026 could result in an upside to earnings outlook, Jarden Research said in a note Tuesday.
The company reported statutory earnings of AU$0.26 per share for the first half of the fiscal year 2025, down from AU$0.274 per share a year earlier. Revenue from ordinary activities rose nearly 20% to AU$1.46 billion from AU$1.22 billion a year earlier.
Jarden Research expects a 1% increase in the company's geochemistry sampling volumes and a further 2.8% improvement in fiscal 2026.
"We expect this could be a positive upside risk to our earnings forecasts, all else remaining equal," the investment firm said.
Jarden Research downgraded ALS to neutral from overweight and raised the target price to AU$14.40 from AU$14.25.
The company shares rose over 1% in recent Thursday trade.
Price (AUD): $15.51, Change: $+0.18, Percent Change: +1.14%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.